Current Report Filing (8-k)
October 21 2019 - 8:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
October 18, 2019
AVALON GLOBOCARE CORP.
(Exact name of registrant as specified in its
charter)
Delaware
|
|
000-55709
|
|
47-1685128
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification Number)
|
4400 Route 9 South, Suite 3100, Freehold, New
Jersey 07728
(Address of principal executive offices) (zip
code)
646-762-4517
(Registrant’s telephone number, including area
code)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
|
☐
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b))
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c))
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
☒
Emerging growth company
If an
emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbols
|
|
Name of each exchange on which registered
|
Common Stock, $0.0001 par value per share
|
|
AVCO
|
|
The Nasdaq Capital Market
|
Item 1.01
|
Entry Into a Material Definitive Agreement
|
On
October 18, 2019, Avalon GloboCare Corp. (the “Company”) and third-party institutional investors (the (“Warrant
Holders”) holding Stock Purchase Warrants to acquire 1,714,288 shares of common stock of the Company (the “Warrants”)
entered into a Warrant Redemption and Cancellation Agreement (the “Redemption Agreement”). The Warrants had an exercise
price of $3.50 per share and were originally issued as part of the Company’s registered direct offering in April 2019. The
Redemption Agreement provides that the Company will redeem the Warrants for a purchase price of approximately $1.4 million with
50% of the Warrants to be redeemed on or before October 25, 2019 and the balance to be redeemed on or before November 8, 2019.
The Warrant Holders may exercise all or some of the Warrants on or prior to the date the Company provides the Warrant Holders with
notice of its intent to close. In the event the Warrant Holders sell the shares of common stock prior to receipt of notice from
the Company, the number of shares to be redeemed and the payment price shall be reduced on a pro-rata basis. The Warrant Holders
may terminate the Redemption Agreement in the event the initial closing does not occur prior to November 1, 2019. Additionally,
to the extent that the final closing has not occurred on or prior to November 14, 2019, then the Warrant Holder shall have the
right to terminate the Company’s rights with respect to the second closing. Following each
closing, the Warrants that were redeemed shall be cancelled.
A copy of the form of Redemption
Agreement is attached to this current report on Form 8-K as Exhibit 10.1 and is incorporated by reference as though it were
fully set forth herein. The foregoing summary description of the Redemption Agreement and the transactions contemplated thereby
is not intended to be complete, and is qualified in its entirety by the complete text of the Redemption Agreement.
Item 1.02
|
Termination of a Material Definitive Agreement
|
See
discussion in Item 1.01 regarding the Redemption Agreement.
Item 9.01
|
Financial Statements and Exhibits
|
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: October 21, 2019
|
By:
|
/s/ Luisa Ingargiola
|
|
Name:
|
Luisa Ingargiola
|
|
Title:
|
Chief Financial Officer
|
2
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Avalon GloboCare (NASDAQ:AVCO)
Historical Stock Chart
From Apr 2023 to Apr 2024